[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cell and Gene Therapy Manufacturing Services Market is segmented by Type (Cell, Gene), Indication (Oncology, Cardiology, Orthopedic, Other), Mode (In-house, Contract), End-user Industry (Pharm & Biotechnology, Academic and Research Institute ),Regional Forecasts 2021-2027

September 2021 | 200 pages | ID: G3911FEE59D4EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Cell and Gene Therapy Manufacturing Services Market is valued approximately at USD 7367.01 million in 2020 and is anticipated to grow with a healthy growth rate of more than 12.34% over the forecast period 2021-2027. The area of cell and gene therapy is revolutionizing way cancer patients and those with genetic disorders are treated. These new therapeutic possibilities enhance patient outcomes dramatically and, in some situations, are curative. However, manufacturing of such medicines poses complex new challenges. The cost of manufacture remains a significant barrier to clinical translation and commercialization of these potentially game-changing medicines today. To manufacture high-quality medications in a reliable and cost-effective manner, new technologies are required. While patients will benefit from new treatment options, the risks for patients and drug developers are high. The market is driven by the key factors such as Increasing investments of pharmaceutical companies in the Research & Development and Increase in the number of chronic diseases, orthopaedic and other cardiovascular diseases. major pharma firms are boosting their R&D efficiency by investing heavily in R&D, in order to ensure long returns on investments, as well as by collaborating with the R&D centres worldwide. for instance: According to Statista, Roche is expected to be the world’s largest company which is investing heavily in R&D, that is, USD 14 Billion followed by Johnson & Johnson (USD 12.2 Billion), Merck & Co (USD 11.4 Billion), Pfizer (USD 10.5 Billion) and Novartis (USD 10 Billion), by the year 2026. However, increasing in the operational costs, may impede market growth over the forecast period of 2021-2027.

Geographically, North America is Dominating the market shares of Cell and gene therapy manufacturing services market owing to rising strategic steps taken by private players and growing number of cancer cases in the region. Furthermore, United States market consists of many prominent players in cell and gene therapy manufacturing services, which are taking strategic steps such as technological advancements, mergers and others to develop new solutions for gene and cell therapy. However, APAC is estimated to be the fastest growing region due to growing development in research and development in cell and gene therapy. Also, China is expected to grow with the highest growth rate during forecast period, due to rising number of approvals by government authorities and growing industrialization of cell and gene therapy in the region

Major market player included in this report are:
Thermo fisher Scientific Inc.
Merck KGaA
Charles River Laboratories
Lonza
Catalent, Inc.
Takara Bio Inc.
Fujifilm Holdings Corporation
Roche Ltd
Wuxi Advanced Therapies
Cell and Gene Therapy Catapult




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Types of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Cell
Gene
By Indication:
Oncology
Cardiology
Orthopedic
Other
By Mode:
In house
Contract
By End user:
Pharma and Biotechnology companies
Academic and research Institute
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Cell and Gene Therapy Manufacturing Services Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
  1.2.1. Cell and Gene therapy Manufacturing Services Market, by region, 2019-2027 (USD Million)
  1.2.2. Cell and Gene therapy Manufacturing Services Market, by Type, 2019-2027 (USD Million)
  1.2.3. Cell and Gene therapy Manufacturing Services Market, by Indication, 2019-2027 (USD Million)
  1.2.4. Cell and Gene therapy Manufacturing Services Market, by Mode, 2019-2027 (USD Million)
  1.2.5. Cell and Gene therapy Manufacturing Services Market, by End user, 2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET DYNAMICS

3.1. Cell and Gene therapy Manufacturing Services Market Impact Analysis (2019-2027)
  3.1.1. Market Drivers
    3.1.1.1. Increasing investments of pharmaceutical companies in the Research & Development
    3.1.1.2. Increase in the number of chronic diseases, orthopaedics and other cardiovascular diseases
  3.1.2. Market Restraint
    3.1.2.1. increasing in the operational costs
  3.1.3. Market Opportunities
    3.1.3.1. increase in the number of clinical therapies for cell and gene therapies

CHAPTER 4. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE

5.1. Market Snapshot
5.2. Global Cell and Gene therapy Manufacturing Services Market by Type, Performance - Potential Analysis
5.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Million)
5.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
  5.4.1. Cell
  5.4.2. Gene

CHAPTER 6. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY INDICATION

6.1. Market Snapshot
6.2. Global Cell and Gene therapy Manufacturing Services Market by Indication, Performance - Potential Analysis
6.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Million)
6.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
  6.4.1. Oncology
  6.4.2. Cardiology
  6.4.3. Orthopaedic
  6.4.4. Others

CHAPTER 7. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY MODE

7.1. Market Snapshot
7.2. Global Cell and Gene therapy Manufacturing Services Market by Mode, Performance - Potential Analysis
7.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Mode 2018-2027 (USD Million)
7.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
  7.4.1. In house manufacturing
  7.4.2. Contract manufacturing

CHAPTER 8. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY END USER INDUSTRY

8.1. Market Snapshot
8.2. Global Cell and Gene therapy Manufacturing Services Market by End user industry, Performance - Potential Analysis
8.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by End user industry 2018-2027 (USD Million)
8.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
  8.4.1. Pharmaceutical and Biotechnology companies
  8.4.2. Academic and research institute

CHAPTER 9. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, REGIONAL ANALYSIS

9.1. Cell and Gene therapy Manufacturing Services Market, Regional Market Snapshot
9.2. North America Cell and Gene therapy Manufacturing Services Market
  9.2.1. U.S. Cell and Gene therapy Manufacturing Services Market
    9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
    9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
    9.2.1.3. Mode breakdown estimates & forecasts, 2018-2027
    9.2.1.4. End User breakdown estimates & forecasts, 2018-2027
  9.2.2. Canada Cell and Gene therapy Manufacturing Services Market
9.3. Europe Cell and Gene therapy Manufacturing Services Market Snapshot
  9.3.1. U.K. Cell and Gene therapy Manufacturing Services Market
  9.3.2. Germany Cell and Gene therapy Manufacturing Services Market
  9.3.3. France Cell and Gene therapy Manufacturing Services Market
  9.3.4. Spain Cell and Gene therapy Manufacturing Services Market
  9.3.5. Italy Cell and Gene therapy Manufacturing Services Market
  9.3.6. Rest of Europe Cell and Gene therapy Manufacturing Services Market
9.4. Asia-Pacific Cell and Gene therapy Manufacturing Services Market Snapshot
  9.4.1. China Cell and Gene therapy Manufacturing Services Market
  9.4.2. India Cell and Gene therapy Manufacturing Services Market
  9.4.3. Japan Cell and Gene therapy Manufacturing Services Market
  9.4.4. Australia Cell and Gene therapy Manufacturing Services Market
  9.4.5. South Korea Cell and Gene therapy Manufacturing Services Market
  9.4.6. Rest of Asia Pacific Cell and Gene therapy Manufacturing Services Market
9.5. Latin America Cell and Gene therapy Manufacturing Services Market Snapshot
  9.5.1. Brazil Cell and Gene therapy Manufacturing Services Market
  9.5.2. Mexico Cell and Gene therapy Manufacturing Services Market
9.6. Rest of The World Cell and Gene therapy Manufacturing Services Market

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Top Market Strategies
10.2. Company Profiles
  10.2.1. Thermo fisher Scientific Inc.
    10.2.1.1. Key Information
    10.2.1.2. Overview
    10.2.1.3. Financial (Subject to Data Availability)
    10.2.1.4. Product Summary
    10.2.1.5. Recent Developments
  10.2.2. Merck KGaA
  10.2.3. Charles River Laboratories
  10.2.4. Lonza
  10.2.5. Catalent, Inc.
  10.2.6. Takara Bio Inc.
  10.2.7. Fujifilm Holdings Corporation
  10.2.8. Roche Ltd
  10.2.9. Wuxi Advanced Therapies
  10.2.10. Cell and Gene Therapy Catapult

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
  11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Cell and Gene therapy Manufacturing Services Market, report scope
TABLE 2. Global Cell and Gene therapy Manufacturing Services Market estimates & forecasts by region 2018-2027 (USD Million)
TABLE 3. Global Cell and Gene therapy Manufacturing Services Market estimates & forecasts by Type 2018-2027 (USD Million)
TABLE 4. Global Cell and Gene therapy Manufacturing Services Market estimates & forecasts by Indication 2018-2027 (USD Million)
TABLE 5. Global Cell and Gene therapy Manufacturing Services Market estimates & forecasts by Mode 2018-2027 (USD Million)
TABLE 6. Global Cell and Gene therapy Manufacturing Services Market estimates & forecasts by End User 2018-2027 (USD Million)
TABLE 7. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 8. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 9. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 10. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 11. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 12. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 13. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 14. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 15. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 16. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 17. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 18. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 19. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 20. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 21. Global Cell and Gene therapy Manufacturing Services Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 22. Global Cell and Gene therapy Manufacturing Services Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 23. U.S. Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 24. U.S. Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 25. U.S. Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 26. Canada Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 27. Canada Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 28. Canada Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 29. UK Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 30. UK Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 31. UK Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 32. Germany Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 33. Germany Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 34. Germany Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 35. France Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 36. France Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 37. France Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 38. Spain Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 39. Spain Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 40. Spain Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 41. Italy Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 42. Italy Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 43. Italy Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 44. ROE Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 45. ROE Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 46. ROE Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 47. China Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 48. China Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 49. China Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 50. India Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 51. India Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 52. India Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 53. Japan Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 54. Japan Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 55. Japan Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 56. Australia Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 57. Australia Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 58. Australia Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 59. South Korea Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 60. South Korea Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 61. South KoreaCell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 62. ROPAC Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 63. ROPAC Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 64. ROPAC Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 65. Brazil Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 66. Brazil Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 67. Brazil Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 68. Mexico Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 69. Mexico Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 70. Mexico Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 71. ROLA Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 72. ROLA Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 73. ROLA Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 74. ROW Cell and Gene therapy Manufacturing Services Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 75. ROW Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 76. ROW Cell and Gene therapy Manufacturing Services Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 77. List of secondary sources used in the study of Global Cell and Gene therapy Manufacturing Services Market.
TABLE 78. List of primary sources used in the study of Global Cell and Gene therapy Manufacturing Services Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.

LIST OF FIGURES

FIG 1. Global Cell and Gene therapy Manufacturing Services Market, research methodology
FIG 2. Global Cell and Gene therapy Manufacturing Services Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cell and Gene therapy Manufacturing Services Market, key trends 2020
FIG 5. Global Cell and Gene therapy Manufacturing Services Market, growth prospects 2021-2027
FIG 6. Global Cell and Gene therapy Manufacturing Services Market, porters 5 force model
FIG 7. Global Cell and Gene therapy Manufacturing Services Market, pest analysis
FIG 8. Global Cell and Gene therapy Manufacturing Services Market, value chain analysis
FIG 9. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 10. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 11. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 12. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 13. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 14. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 15. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 16. Global Cell and Gene therapy Manufacturing Services Market by segment, 2018 & 2027 (USD Million)
FIG 17. Global Cell and Gene therapy Manufacturing Services Market, regional snapshot 2018 & 2027
FIG 18. North America Cell and Gene therapy Manufacturing Services Market 2018 & 2027 (USD Million)
FIG 19. Europe Cell and Gene therapy Manufacturing Services Market 2018 & 2027 (USD Million)
FIG 20. Asia-Pacific Cell and Gene therapy Manufacturing Services Market 2018 & 2027 (USD Million)
FIG 21. Latin America Cell and Gene therapy Manufacturing Services Market 2018 & 2027 (USD Million)
FIG 22. Global Cell and Gene therapy Manufacturing Services Market, company market share analysis (2020)


More Publications